Time Left for Intervention in the Suicidal Process in Borderline Personality Disorder

The objective of this study was to measure the duration of the suicidal process among patients diagnosed with Borderline Personality Disorder (BPD). The sample included 110 female patients who met DSM-IV-TR criteria for BPD and were consecutively admitted after suicide-related behavior. A total of 63 patients (58%) reported that their suicidal process lasted 10 minutes or less. After being adjusted, the β coefficient of impulsivity scales in women with a suicidal process ≤10 minutes was lower compared to those observed in women with >10 min (β = −0.03, 95% CI = −0.06 = −0.01, p < 0.01). Suicidal patients with BPD can be divided into two groups; patients who report a suicidal process less than 10 minutes show a higher degree of impulsivity.Fil: Daray, Federico Manuel. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Teti, Germán Leandro. Gobierno de la Ciudad de Buenos Aires. Hospital Neuropsiquiátrico "Braulio A. Moyano"; ArgentinaFil: Rojas, Sasha M.. University Of Arkansas - Fayetteville; Estados UnidosFil: Fantini, Adrian Pablo. Gobierno de la Ciudad de Buenos Aires. Hospital Neuropsiquiátrico "Braulio A. Moyano"; ArgentinaFil: Cárdenas Delgado, Christian. Gobierno de la Ciudad de Buenos Aires. Hospital Neuropsiquiátrico "Braulio A. Moyano"; ArgentinaFil: Armesto, Arnaldo Raúl. Universidad de Buenos Aires. Facultad de Medicina; ArgentinaFil: Derito, María N. C.. Gobierno de la Ciudad de Buenos Aires. Hospital Neuropsiquiátrico "Braulio A. Moyano"; ArgentinaFil: Rebok, Federico. Gobierno de la Ciudad de Buenos Aires. Hospital Neuropsiquiátrico "Braulio A. Moyano"; Argentin

Types of Borderline Personality Disorder (BPD) in patients admitted for suicide-related behavior

Borderline personality disorder (BPD) is determined by the presence of any five of nine diagnostic criteria, leading patients with heterogeneous clinical features to be diagnosed under the same label without an individualized clinical and therapeutic approach. In response to this problem, Oldham proposed five types of BPD: affective, impulsive, aggressive, dependent and empty. The present study categorized a sample of BPD patients hospitalized due to suicide-related behavior according to Oldham’s BPD proposed subtypes, and evaluated their clinical and demographic characteristics. Data were obtained from a sample of 93 female patients admitted to the « Dr. Braulio A. Moyano » Neuropsychiatric Hospital following suicide-related behavior. A total of 87 patients were classified as affective (26 %), impulsive (37 %), aggressive (4 %), dependent (29 %), and empty (5 %). Patients classified as dependent were significantly older at the time of first suicide-related behavior (p = 0.0008) and reported significantly less events of previous suicide-related behaviors (p = 0.03), while patients classified as impulsive reported significantly higher rates of drug use (p = 0.02). Dependent, impulsive and affective BPD types were observed most frequently in our sample. Findings are discussed specific to demographic and clinical implications of BPD patients reporting concurrent suicidal behavior.Fil: Rebok, Federico. Universidad de Buenos Aires. Facultad de Medicina. Cátedra de Farmacología; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital "Dr. Braulio A. Moyano"; Argentina. Gobierno de la Ciudad de Buenos Aires; ArgentinaFil: Teti, Germán L.. Universidad de Buenos Aires. Facultad de Medicina. Cátedra de Farmacología; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital "Dr. Braulio A. Moyano"; ArgentinaFil: Fantini, Adrián P.. Gobierno de la Ciudad de Buenos Aires. Hospital "Dr. Braulio A. Moyano"; ArgentinaFil: Cárdenas Delgado, Christian. Gobierno de la Ciudad de Buenos Aires. Hospital "Dr. Braulio A. Moyano"; ArgentinaFil: Rojas, Sasha M.. University of Arkansas; Estados UnidosFil: Derito, María N. C.. Gobierno de la Ciudad de Buenos Aires. Hospital "Dr. Braulio A. Moyano"; ArgentinaFil: Daray, Federico Manuel. Universidad de Buenos Aires. Facultad de Medicina. Cátedra de Farmacología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin